139 related articles for article (PubMed ID: 8103122)
1. [PCNA (proliferating cell nuclear antigen) expression in adenocarcinomas < 2 cm of the peripheral lung].
Koshikawa T; Nakamura S; Kitoh K; Hayashi K; Suyama M; Kunishima K
Rinsho Byori; 1993 Jun; Suppl 94():113-24. PubMed ID: 8103122
[No Abstract] [Full Text] [Related]
2. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
3. [Flow cytometric techniques for measurement of proliferating cell nuclear antigen (PCNA)].
Ichikawa A; Shimamura K; Koyama Y
Nihon Rinsho; 1992 Oct; 50(10):2343-8. PubMed ID: 1360029
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of AgNORs in lung cancer].
Abe S
Rinsho Byori; 1993 Jun; Suppl 94():104-12. PubMed ID: 8361003
[No Abstract] [Full Text] [Related]
5. [Contribution of proliferating cell nuclear antigen to prognostic evaluation of carcinomas of the maxillary sinus].
Mikuni H; Fukuda S; Furuta Y; Takasu T; Nagahashi T; Inuyama Y
Nihon Jibiinkoka Gakkai Kaiho; 1992 Dec; 95(12):1944-9. PubMed ID: 1362772
[TBL] [Abstract][Full Text] [Related]
6. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
7. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
8. Proliferating nuclear antigen (PCNA) as a prognostic factor of squamous cell carcinoma of the oesophagus.
Dabrowski A; Szumiło J; Brajerski G; Wallner G
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():59-67. PubMed ID: 11977365
[TBL] [Abstract][Full Text] [Related]
9. Tumor histology affects the accuracy of clinical evaluative staging in primary lung cancer.
Funakoshi Y; Maeda H; Takeda S; Nojiri T; Kawamura T
Lung Cancer; 2010 Nov; 70(2):195-9. PubMed ID: 20621386
[TBL] [Abstract][Full Text] [Related]
10. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
Bellotti M; Elsner B; Paez De Lima A; Esteva H; Marchevsky AM
Mod Pathol; 1997 Dec; 10(12):1221-7. PubMed ID: 9436967
[TBL] [Abstract][Full Text] [Related]
11. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
13. [Application of image analysis and flow cytometry for lung cancer cytology].
Konaka C; Kato H; Ikeda N; Shimizu E; Kamura T
Rinsho Byori; 1993 Jun; Suppl 94():66-75. PubMed ID: 8103125
[No Abstract] [Full Text] [Related]
14. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M; Koomägi R
Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
[TBL] [Abstract][Full Text] [Related]
16. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
18. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between magnetic resonance imaging findings and proliferating cell nuclear antigen expression in peripheral lung cancer].
Xiang ZM; Hu YS; Zhao SY; Tan LL; Li ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2230-2. PubMed ID: 19114366
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of proliferating cell nuclear antigen in lung cancer: an immunohistochemical analysis.
Caputi M; Esposito V; Groger AM; Pacilio C; Murabito M; Dekan G; Baldi F; Wolner E; Giordano A
In Vivo; 1998; 12(1):85-8. PubMed ID: 9575430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
